Perinatal-lethal nonimmune fetal hydrops attributed to MECOM -associated bone marrow failure
Molecular Case Studies · 2023
DOI: 10.1101/mcs.a006289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Case Studies, 2023. Verfasst von Camille A Dash und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. Hauptthemen laut MEDLINE: Anemia, Hydrops Fetalis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Pathogenic variants in MECOM , a gene critical to the self-renewal and proliferation of hematopoietic stem cells, are known to cause a rare bone marrow failure syndrome associated with amegakaryocytic thrombocytopenia and bilateral radioulnar synostosis known as RUSAT2. However, the spectrum of disease seen with causal variants in MECOM is broad, ranging from mildly affected adults to fetal loss. We report two cases of infants born preterm who presented at birth with symptoms of bone marrow failure including severe anemia, hydrops, and petechial hemorrhages; radioulnar synostosis was not observed in either patient, and, unfortunately, neither infant survived. In both cases, genomic sequencing revealed de novo variants in MECOM considered to be responsible for their severe presentations. These cases add to the growing body of literature that describe MECOM -associated disease, particularly MECOM as a cause of fetal hydrops due to bone marrow failure in utero. Furthermore, they support the use of a broad sequencing approach for perinatal diagnosis, as MECOM is absent from available targeted gene panels for hydrops, and highlight the importance of postmortem genomic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
- Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
- The Manton Center for Orphan Disease Research, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
- Division of Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Nationwide Children's Hospital and the Ohio State University College of Medicine, Columbus, Ohio 43205, USA.
- Division of Neonatology, Department of Pediatrics, Nationwide Children's Hospital and the Ohio State University College of Medicine, Columbus, Ohio 43205, USA.
- Division of Genetics and Genomic Medicine, Department of Pediatrics, Nationwide Children's Hospital and the Ohio State University College of Medicine, Columbus, Ohio 43205, USA.
ORCID-Profile: Christy Cummings, Mari Mori, Bimal P Chaudhari, Monica H Wojcik
Förderung
- NHGRI NIH HHS
- NICHD NIH HHS
Zitieren
APA
Dash, C. A., Madden, J. A., Cummings, C., Rose, M., Wilson, S. D., Mori, M., Agrawal, P. B., Chaudhari, B. P., & Wojcik, M. H. (2023). Perinatal-lethal nonimmune fetal hydrops attributed to MECOM -associated bone marrow failure. Molecular Case Studies. https://doi.org/10.1101/mcs.a006289
Vancouver
Dash CA, Madden JA, Cummings C, Rose M, Wilson SD, Mori M, et al. Perinatal-lethal nonimmune fetal hydrops attributed to MECOM -associated bone marrow failure. Molecular Case Studies. 2023. doi:10.1101/mcs.a006289
BibTeX
@article{Dash2023,
author = {Dash, Camille A and Madden, Jill A and Cummings, Christy and Rose, Melissa and Wilson, Sheria D and Mori, Mari and Agrawal, Pankaj B and Chaudhari, Bimal P and Wojcik, Monica H},
title = {Perinatal-lethal nonimmune fetal hydrops attributed to MECOM -associated bone marrow failure},
journal = {Molecular Case Studies},
year = {2023},
doi = {10.1101/mcs.a006289}
}
EUVIMED